Author:
Escobar Ignacio G.,Alonso Pilar T.,Barrigon Dolores C.,Perez-Simon Jose A.,Mateos Manteca Maria V.,San Miguel Izquierdo Jesus F.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference52 articles.
1. De Vita VT Jr, Canellos GP, Chapner B, Schein P, Hubbard SP, Young RC. Advanced diffuse histiocytic lymphoma: a potentially curable disease. Lancet 1975;1:248–250.
2. Armitage JO. Drug therapy: treatment of non-Hodgkin’s lymphoma. N Engl J Med 1993;328:1023–1030.
3. Fisher RI, Gainor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 1993;328:1002–1006.
4. Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin’s lymphomas: report of the jury (review). J Clin Oncol 1999;17:423–429.
5. Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Adrien F, et al. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients with LNH-84 regimen. J Clin Oncol 1992;10:1615–1623.